First Time Loading...

Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 7.56 USD 2.86% Market Closed
Updated: Apr 30, 2024

Wall Street
Price Targets

CDMO Price Targets Summary
Avid Bioservices Inc

Wall Street analysts forecast CDMO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDMO is 12.5 USD with a low forecast of 7.07 USD and a high forecast of 16.8 USD.

Lowest
Price Target
7.07 USD
6% Downside
Average
Price Target
12.5 USD
65% Upside
Highest
Price Target
16.8 USD
122% Upside
Avid Bioservices Inc Competitors:
Price Targets
PHARM
Pharming Group NV
105% Upside
4974
Takara Bio Inc
101% Upside
688278
Xiamen Amoytop Biotech Co Ltd
19% Downside
RXRX
Recursion Pharmaceuticals Inc
62% Upside
STOK
Stoke Therapeutics Inc
104% Upside
TNGX
Tango Therapeutics Inc
128% Upside
300406
Beijing Strong Biotechnologies Inc
19% Upside
358570
GI Innovation Inc
85% Upside

Revenue
Forecast

Revenue Estimate
Avid Bioservices Inc

For the last 8 years the compound annual growth rate for Avid Bioservices Inc's revenue is 24%. The projected CAGR for the next 4 years is 15%.

24%
Past Growth
15%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Avid Bioservices Inc

The compound annual growth rate of Avid Bioservices Inc's operating income for the next 4 years is 80%.

N/A
Past Growth
80%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Avid Bioservices Inc

The compound annual growth rate of Avid Bioservices Inc's net income for the next 3 years is 168%.

N/A
Past Growth
168%
Estimated Growth
Estimates Accuracy
-34%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CDMO's stock price target?
Price Target
12.5 USD

According to Wall Street analysts, the average 1-year price target for CDMO is 12.5 USD with a low forecast of 7.07 USD and a high forecast of 16.8 USD.

What is Avid Bioservices Inc's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for Avid Bioservices Inc's revenue is 24%. The projected CAGR for the next 4 years is 15%.

What is Avid Bioservices Inc's Operating Income forecast?
Projected CAGR
80%

The compound annual growth rate of Avid Bioservices Inc's operating income for the next 4 years is 80%.

What is Avid Bioservices Inc's Net Income forecast?
Projected CAGR
168%

The compound annual growth rate of Avid Bioservices Inc's net income for the next 3 years is 168%.